Gene editing in plants remains challenging, with the traditional non-homologous end-joining (cNHEJ) repair pathway often hindering precision. In this study, researchers advanced CRISPR-Cas-based gene ...
Hosted on MSN
CRISPR-based gene editing revolutionized medicine—the company that helped develop it says that's just the beginning
Since its discovery in 2011, CRISPR-Cas 9 has revolutionized medicine. One of the companies at the forefront of this revolution is CRISPR Therapeutics. Chief Justice Roberts Sets Record Straight On ...
The first in-human trial of a CRISPR Cas system delivered by adeno-associated virus 9 gene therapy to treat HIV was able to target only the intended DNA and cleared the blood within 6 months.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback